세계의 전사체학 시장 보고서(2025년)
Transcriptomics Global Market Report 2025
상품코드 : 1760731
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

전사체학 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 8.1%의 연평균 복합 성장률(CAGR)로 96억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안 예상되는 성장은 단일 세포 리보핵산 서열의 채택 증가, 공간 전사체학의 통합 증가, 멀티오믹스 접근법에 대한 수요 증가, 질병의 조기 발견에 대한 관심 증가, 비코드 리보핵산의 중요성에 대한 인식이 높아짐에 따라 이루어질 것입니다. 예측 기간의 주요 동향으로는 차세대 염기서열 분석(NGS) 기술의 발전, 공간적 전사체학의 혁신, 생물정보학 도구의 개선, 전사체학에 머신러닝의 통합, 실시간 전사체 분석 기술의 발전 등이 있습니다.

맞춤형 의료의 채택 확대가 향후 트랜스스크립믹스 시장의 성장을 견인할 것으로 예측됩니다. 맞춤의료는 개인의 유전적 체질, 생활습관, 환경적 요인에 따라 맞춤형 치료를 제공하는 것을 의미합니다. 이 접근법은 유전자 염기서열 분석의 발전으로 개인의 유전자 프로파일에 맞는 치료가 가능해져 더 높은 효과를 얻을 수 있게 되었기 때문에 많은 지지를 받고 있습니다. 트랜스스크립틱스는 고유한 유전자 발현 패턴을 밝혀냄으로써 보다 효과적이고 부작용을 줄이며, 질병의 조기 진단을 지원하는 개인 맞춤형 치료를 가능하게 합니다. 예를 들어, 2024년 2월 개인맞춤의료연합(Personalized Medicine Coalition)은 FDA가 2023년 희귀질환에 대한 16건의 새로운 개인맞춤형 치료제를 승인했다고 보고했습니다. 그 결과, 맞춤형 의료의 보급이 트랜스스크립믹스 시장의 성장에 기여하고 있습니다.

트랜스크립틱스 시장 업체들은 세포 기능 및 질병 메커니즘에 대한 더 깊은 통찰력을 얻기 위해 단일 세포 공간 패널과 같은 혁신적인 제품 개발에 집중하고 있습니다. 단일 세포 공간 패널은 조직 내 세포의 위치를 유지하면서 개별 세포 수준에서 유전자 발현을 분석합니다. 이 패널은 단일 세포 전사체 분석과 공간 데이터를 결합하여 세포 활동과 조직 구조에 대한 통찰력을 제공합니다. 예를 들어, 2024년 2월 NanoString Technologies는 CosMx 6,000 plex RNA Assay를 출시했습니다. CosMx Spatial Molecular Imager(SMI) 용으로 설계된 이 획기적인 제품은 거의 모든 인간 생물학적 경로에 걸쳐 6,000개 이상의 RNA 타겟을 측정할 수 있는 최초의 상업용 단일 세포 공간 패널입니다. 세분화를 통해 단일 세포 및 세포 내 해상도로 유전자 프로파일링을 수행할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나재난과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

LSH
영문 목차

영문목차

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts generated by the genome within a specific cell, tissue, or condition. It aids in deciphering gene expression patterns and regulatory processes, revealing how they change in response to diseases or environmental influences. This field provides valuable insights into cellular functions and disease mechanisms. Transcriptomics plays a key role in biomarker discovery, identifying therapeutic targets, and advancing personalized medicine.

The primary categories of transcriptomics include instruments, consumables, software, and services. Instruments are vital in transcriptomics as they allow for the precise analysis of gene expression through high-throughput sequencing, amplification, and RNA detection. Various technologies are employed, such as microarrays, real-time quantitative polymerase chain reaction, and sequencing technologies. These tools are used for multiple applications, including diagnostics, disease profiling, drug discovery, and others, and are utilized by a wide range of end-users, such as academic and research institutions, pharmaceutical companies, biotechnology firms, and more.

The transcriptomics market research report is one of a series of new reports from The Business Research Company that provides transcriptomics market statistics, including the transcriptomics industry global market size, regional shares, competitors with the transcriptomics market share, detailed transcriptomics market segments, market trends, and opportunities, and any further data you may need to thrive in the transcriptomics industry. This transcriptomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transcriptomics market size has grown strongly in recent years. It will grow from $6.51 billion in 2024 to $7.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the past can be attributed to an increasing emphasis on personalized medicine, a rising prevalence of cancer, the incorporation of genomics in clinical diagnostics, the expansion of ribonucleic acid sequencing, and a growing demand for biomarker discovery.

The transcriptomics market size is expected to see strong growth in the next few years. It will grow to $9.65 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The expected growth in the forecast period is driven by the rising adoption of single-cell ribonucleic acid sequencing, the increasing integration of spatial transcriptomics, the growing demand for multiomics approaches, a heightened focus on early disease detection, and greater awareness of the significance of non-coding ribonucleic acids. Key trends for the forecast period include advancements in next-generation sequencing (NGS) technologies, innovations in spatial transcriptomics, improvements in bioinformatics tools, the integration of machine learning in transcriptomics, and progress in real-time transcriptomic analysis technologies.

The growing adoption of personalized medicine is expected to drive the growth of the transcriptomics market in the future. Personalized medicine involves customizing treatments based on an individual's genetic makeup, lifestyle, and environmental factors. This approach is gaining traction due to advancements in genetic sequencing, which allow for treatments tailored to a person's genetic profile for greater effectiveness. Transcriptomics helps uncover unique gene expression patterns, enabling personalized treatments that are more effective, reduce side effects, and support early disease diagnosis. For example, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, compared to just six in 2022. As a result, the increasing adoption of personalized medicine is contributing to the growth of the transcriptomics market.

Companies in the transcriptomics market are focused on developing innovative products such as single-cell spatial panels to gain deeper insights into cellular functions and disease mechanisms. Single-cell spatial panels analyze gene expression at the individual cell level while preserving the cells' positions within the tissue. These panels combine single-cell transcriptomics with spatial data, providing insights into both cellular activity and tissue structure. For instance, in February 2024, NanoString Technologies launched the CosMx 6,000 plex RNA Assay, the first commercial single-cell spatial panel capable of measuring over 6,000 RNA targets across nearly all human biological pathways. This breakthrough, designed for use with the CosMx Spatial Molecular Imager (SMI), enables researchers to profile genes at single-cell and subcellular resolution with high accuracy and advanced cell segmentation.

In July 2024, Illumina, Inc., a U.S.-based provider of DNA sequencing and array-based technologies, acquired Fluent BioSciences for an undisclosed amount. This acquisition aims to enhance Illumina's multiomics capabilities by integrating Fluent's innovative, scalable single-cell technology, which eliminates the need for complex and expensive equipment. This enables faster, more cost-effective, and comprehensive discoveries in genomics and cell biology. Fluent BioSciences specializes in single-cell analysis technology, a key method in transcriptomics that allows researchers to profile gene expression at the individual cell level.

Major players in the transcriptomics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies plc, Genewiz Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Singleron Biotechnologies, SCIEX, CD Genomics Inc., Parse Biosciences Inc., Lexogen GmbH, LC Sciences LLC, and Arraystar Inc.

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in transcriptomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the transcriptomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transcriptomics market consists of revenues earned by entities by providing services such as voice gene expression analysis, ribonucleic acid sequencing, bioinformatics solutions, and data interpretation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The transcriptomics market also includes sales of RNA extraction kits, library preparation kits, and cDNA synthesis kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transcriptomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transcriptomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for transcriptomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transcriptomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Transcriptomics Market Characteristics

3. Transcriptomics Market Trends And Strategies

4. Transcriptomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Transcriptomics Growth Analysis And Strategic Analysis Framework

6. Transcriptomics Market Segmentation

7. Transcriptomics Market Regional And Country Analysis

8. Asia-Pacific Transcriptomics Market

9. China Transcriptomics Market

10. India Transcriptomics Market

11. Japan Transcriptomics Market

12. Australia Transcriptomics Market

13. Indonesia Transcriptomics Market

14. South Korea Transcriptomics Market

15. Western Europe Transcriptomics Market

16. UK Transcriptomics Market

17. Germany Transcriptomics Market

18. France Transcriptomics Market

19. Italy Transcriptomics Market

20. Spain Transcriptomics Market

21. Eastern Europe Transcriptomics Market

22. Russia Transcriptomics Market

23. North America Transcriptomics Market

24. USA Transcriptomics Market

25. Canada Transcriptomics Market

26. South America Transcriptomics Market

27. Brazil Transcriptomics Market

28. Middle East Transcriptomics Market

29. Africa Transcriptomics Market

30. Transcriptomics Market Competitive Landscape And Company Profiles

31. Transcriptomics Market Other Major And Innovative Companies

32. Global Transcriptomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Transcriptomics Market

34. Recent Developments In The Transcriptomics Market

35. Transcriptomics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기